UK Markets close in 3 hrs 18 mins
  • FTSE 100

    6,918.09
    +27.60 (+0.40%)
     
  • FTSE 250

    22,350.58
    +82.12 (+0.37%)
     
  • AIM

    1,245.40
    -0.21 (-0.02%)
     
  • GBP/EUR

    1.1503
    +0.0001 (+0.01%)
     
  • GBP/USD

    1.3764
    +0.0012 (+0.0840%)
     
  • BTC-GBP

    46,850.55
    +1,013.54 (+2.21%)
     
  • CMC Crypto 200

    1,390.24
    +96.25 (+7.44%)
     
  • S&P 500

    4,141.59
    +13.60 (+0.33%)
     
  • DOW

    33,677.27
    -68.13 (-0.20%)
     
  • CRUDE OIL

    61.24
    +1.06 (+1.76%)
     
  • GOLD FUTURES

    1,745.10
    -2.50 (-0.14%)
     
  • NIKKEI 225

    29,620.99
    -130.62 (-0.44%)
     
  • HANG SENG

    28,900.83
    +403.58 (+1.42%)
     
  • DAX

    15,230.17
    -4.19 (-0.03%)
     
  • CAC 40

    6,214.71
    +30.61 (+0.49%)
     

Sepsis Diagnostic Market Research Report by Product, by Technology, by Pathogen, by Testing Type - Global Forecast to 2025 - Cumulative Impact of COVID-19

ReportLinker
·5-min read

Sepsis Diagnostic Market Research Report by Product (Assay Kits and Reagents, Blood Culture Media, Instruments, and Software), by Technology (Flow Cytometry, Immunoassays, Microbiology, and Molecular Diagnostics), by Pathogen, by Testing Type - Global Forecast to 2025 - Cumulative Impact of COVID-19

New York, April 06, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Sepsis Diagnostic Market Research Report by Product, by Technology, by Pathogen, by Testing Type - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p06045521/?utm_source=GNW

Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Sepsis Diagnostic Market is expected to grow from USD 421.85 Million in 2020 to USD 646.95 Million by the end of 2025.
2. The Global Sepsis Diagnostic Market is expected to grow from EUR 369.88 Million in 2020 to EUR 567.25 Million by the end of 2025.
3. The Global Sepsis Diagnostic Market is expected to grow from GBP 328.82 Million in 2020 to GBP 504.29 Million by the end of 2025.
4. The Global Sepsis Diagnostic Market is expected to grow from JPY 45,022.08 Million in 2020 to JPY 69,045.95 Million by the end of 2025.
5. The Global Sepsis Diagnostic Market is expected to grow from AUD 612.58 Million in 2020 to AUD 939.45 Million by the end of 2025.

Market Segmentation & Coverage:
This research report categorizes the Sepsis Diagnostic to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the Sepsis Diagnostic Market studied across Assay Kits and Reagents, Blood Culture Media, Instruments, and Software. The Assay Kits and Reagents further studied across Flow Cytometry, Immunoassays, Microbiology, and Molecular Diagnostics. The Blood Culture Media further studied across Flow Cytometry, Immunoassays, Microbiology, and Molecular Diagnostics. The Instruments further studied across Flow Cytometry, Immunoassays, Microbiology, and Molecular Diagnostics. The Software further studied across Flow Cytometry, Immunoassays, Microbiology, and Molecular Diagnostics.

Based on Technology, the Sepsis Diagnostic Market studied across Flow Cytometry, Immunoassays, Microbiology, and Molecular Diagnostics.

Based on Pathogen, the Sepsis Diagnostic Market studied across Bacterial Sepsis and Fungal Sepsis. The Bacterial Sepsis further studied across Gram-Negative Bacteria and Gram-Positive Bacteria.

Based on Testing Type, the Sepsis Diagnostic Market studied across Laboratory Testing and PoC Testing.

Based on Geography, the Sepsis Diagnostic Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Sepsis Diagnostic Market including Abbott Laboratories, Alifax S.r.l., Alpa Laboratories Ltd, Amara Health Analytics, Inc., Axis-Shield Diagnostics, Beckman Coulter, Inc., Becton, Dickinson and Company, bioMérieux SA, Boditech Med, Bruker Corporation, Cerner Corporation, CytoSorbents Corporation, Danaher Corporation, EKF Diagnostics, Epic Systems Corporation, F. Hoffmann-La Roche AG, GE Healthcare, GenMark Diagnostics, Immunexpress Inc., Koninklijke Philips N.V., Luminex Corporation, McKesson Corporation, Response Biomedical Corporation, SEEGENE, Inc, Thermo Fisher Scientific, Inc., and Wolters Kluwer N.V..

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Sepsis Diagnostic Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Sepsis Diagnostic Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Sepsis Diagnostic Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Sepsis Diagnostic Market?
4. What is the competitive strategic window for opportunities in the Global Sepsis Diagnostic Market?
5. What are the technology trends and regulatory frameworks in the Global Sepsis Diagnostic Market?
6. What are the modes and strategic moves considered suitable for entering the Global Sepsis Diagnostic Market?
Read the full report: https://www.reportlinker.com/p06045521/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001